• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
  • View Item
  •   LillOA Home
  • Liste des unités
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

French consensus: treatment of newly ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique: Article de synthèse/Review paper
DOI :
10.1016/j.neurol.2018.06.002
PMID :
30054010
Permalink :
http://hdl.handle.net/20.500.12210/15926
Title :
French consensus: treatment of newly diagnosed restless legs syndrome
Author(s) :
Limousin, N. [Auteur]
Flamand, Mathilde [Auteur]
Schroder, C. [Auteur]
Monaca, C. Charley [Auteur]
Journal title :
Revue neurologique
Abbreviated title :
Rev. Neurol.
Volume number :
174
Pages :
515-521
Publication date :
2018-09-01
ISSN :
0035-3787
English keyword(s) :
Dopaminergic agonists
A2 delta ligands
Opioids
Restless legs syndrome
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Treatment of restless legs syndrome (RLS) must only be considered after a definite positive diagnosis. The RLS phenotype must be characterised precisely, iron deficiency always tested for, and aggravating factors eliminated ...
Show more >
Treatment of restless legs syndrome (RLS) must only be considered after a definite positive diagnosis. The RLS phenotype must be characterised precisely, iron deficiency always tested for, and aggravating factors eliminated when possible. Medical treatment is considered for severe or very severe forms and based on dopaminergic agonists, α2δ-1 ligands and/or opioids. First line treatment will be a low-dose monotherapy and the choice of treatment depends on the results of the clinical examination and investigations.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
CNRS
Inserm
Université de Lille
Collections :
  • Lille Neurosciences & Cognition (LilNCog) - U 1172
Research team(s) :
Troubles cognitifs dégénératifs et vasculaires
Submission date :
2019-11-27T13:02:25Z
Université de Lille

Mentions légales
Université de Lille © 2017